Thromboembolism (DBCOND0022145)

Identifiers

Synonyms
Thrombo-embolism / Thrombus / Thromboembolic event / Thromboembolic disorder (disorder) / Thromboembolism NOS / Thromboembolus (morphologic abnormality) / Thrombus (morphologic abnormality) / Clot blood / Blood clot (morphologic abnormality) / Embolism / Embolism (disorder) / Embolism NOS / Thrombosis / Thrombotic disorder (disorder) / Thrombosis (disorder) / Thrombosis NOS / Thrombosis (qualifier value)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Acetylsalicylic acid
A salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events.
Bemiparin
An ultra-low molecular weight heparin (ultra-LMWH) used to prevent thromboembolism following surgery and extracorporeal clotting during dialysis.
Heparin
An anticoagulant indicated for thromboprophylaxis and to treat thrombosis associated with a variety of conditions such as pulmonary embolism and atrial fibrillation.
Reviparin
By the FDA, reviparin is indicated for the treatment of deep vein which may lead to pulmonary embolism in pediatric patients. It is also indicated for the long-term treatment of...
No drug targets
Triflusal
A medication related to acetylsalicylic acid with antithrombotic effects used in the treatment of thromboembolic diseases.
Warfarin
A vitamin K antagonist used to treat venous thromboembolism, pulmonary embolism, thromboembolism with atrial fibrillation, thromboembolism with cardiac valve replacement, and thromboembolic events post myocardial infarction.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT01747746
Anticoagulation With Rivaroxaban in Cardioversion -The ARC Studytreatment4completed
NCT06627933
Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint ReplacementNo drug interventionsNot AvailableNot Availablerecruiting
NCT05643885
A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03581877
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PEtreatment4active_not_recruiting
NCT02376803
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCTtreatment4completed
NCT04746521
Cellular-Mediated Immunity in COVID-19No drug interventionsNot AvailableNot Availableunknown_status
NCT00433602
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT00986154
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).treatment3completed
NCT02935751
Apixaban Discontinuation Prior to Major SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT05067153
Thromboprophylaxis in Oesophageal Cancer Patientsprevention4unknown_status
NCT03914053
Balancing of Patients Treated by Vitamin K Antagonists (VKAS) in General MedicineNo drug interventionsNot AvailableNot Availablecompleted
NCT00967447
Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement SurgeryNo drug interventionsNot AvailableNot Availableterminated
NCT01203098
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplastyprevention2completed
NCT03893461
Coagulation System In STereotactic Radiotherapy Of NSCLCNo drug interventionsNot AvailableNot Availableunknown_status
NCT04199793
Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist DeviceNo drug interventionssupportive_careNot Availableterminated
NCT00152971
Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacementprevention3completed
NCT00353678
Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)prevention2completed
NCT00260988
A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgeryprevention2 / 3completed
NCT04258488
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacementtreatment4recruiting
NCT00846807
Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT00375609
Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)prevention2completed
NCT00504556
A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillationprevention2completed
NCT00094185
Clotting Genetic Variants, Hormones, and Venous ThrombosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00486915
Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke IncidenceNo drug interventionspreventionNot Availablecompleted
NCT00139815
Michelangelo - Oasis 5treatment3completed
NCT03073915
Evaluation of the Risk of VTE Among Patients Hospitalized in Non-surgical DepartmentsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05625932
TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancerprevention3recruiting
NCT00014352
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancertreatment2completed
NCT04394000
Impact of an Intensified Thromboprofylaxis Protocol in COVID-19No drug interventionsNot AvailableNot Availablecompleted
NCT00205400
Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation CareNo drug interventionstreatmentNot Availablecompleted
NCT02584842
Rivaroxaban in Endovenous Laser Ablation With and Without MiniphlebectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT00168818
Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgeryprevention3completed
NCT00320424
Hip Fracture Study of GSK576428 (Fondaparinux Sodium)prevention3completed
NCT05656963
The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKDNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00680186
Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)treatment3completed
NCT00408239
Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacementprevention2completed
NCT05162339
Inflammatory Bowel Disease and Thromboembolic EventsNo drug interventionsNot AvailableNot Availablecompleted
NCT00328939
ARIXTRA Local Study For Registration In China.prevention3completed
NCT02579122
REVIparin-BRIDging-in a General Practice Setting in GErmanyNo drug interventionsNot AvailableNot Availableterminated
NCT00655122
Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Studyprevention4terminated
NCT03424330
Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence.No drug interventionsotherNot Availablerecruiting
NCT05301348
In Vivo Detection of Circulating Clots in Patients With ThromboembolismNo drug interventionsdiagnosticNot Availablerecruiting
NCT06118957
Low Molecular Weight Heparin or no Treatment Following Cesarean Deliveryprevention2completed
NCT05796557
ECMO Hemostatic Transfusions in ChildrenNo drug interventionstreatment4recruiting
NCT05794165
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous ThromboembolismNo drug interventionstreatment2enrolling_by_invitation
NCT04997265
Strategies for Anticoagulation During Venovenous ECMONo drug interventionstreatmentNot Availablerecruiting
NCT04246073
Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for ThromboembolismNo drug interventionsNot AvailableNot Availableunknown_status
NCT02970773
Absorption of Rivaroxaban in Patients With Cervical Spinal Cord Injuryother4withdrawn
NCT01696760
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncologysupportive_careNot Availablecompleted
NCT00266994
HTRS TE Registry (ThromboEmbolism Registry)No drug interventionsNot AvailableNot Availablecompleted
NCT00927862
Applying Pharmacogenetic Algorithms to Individualize Dosing of WarfarinNo drug interventionstreatment2 / 3completed
NCT00011180
Risk Factors for Venous Thromboembolism in the CommunityNo drug interventionsNot AvailableNot Availablecompleted
NCT00206089
Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Eventsprevention3terminated
NCT03359889
PraxbindTM India PMS ProgramNot AvailableNot Availablecompleted
NCT00796692
Nadroparin for the Initial Treatment of Pulmonary Thromboembolismtreatment4completed
NCT06065592
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphismsprevention1recruiting
NCT00371501
Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosusprevention4completed
NCT00911001
SALTO - Epidemiological Study on Compliance and Treatment SatisfactionNo drug interventionsNot AvailableNot Availablecompleted
NCT04072068
Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapytreatment4completed
NCT00799968
12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in Chinatreatment4completed
NCT00253669
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed GliomasNo drug interventionsNot AvailableNot Availablecompleted
NCT00451412
A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patientsprevention3completed
NCT02864810
Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in ThromboembolismNo drug interventionsdiagnostic1completed
NCT02295150
Prophylaxis of Venous Thromboembolism After Bariatric Surgeryprevention4unknown_status
NCT00329238
Secondary Prevention of Venous Thrombo Embolism (VTE).treatment3completed
NCT00096590
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT02522221
Tecarfarin Anti-Coagulation Trial (TACT)treatment3unknown_status
NCT02313584
Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Riskprevention3unknown_status
NCT00868179
A Cohort Study With 100 Subjects Having a Primary Total Knee Replacement, Taking Pradax Post Discharge for Ten Daystreatment4withdrawn
NCT02475187
Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur FractureNo drug interventionsNot AvailableNot Availableterminated
NCT01132833
Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT01006733
Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVTNo drug interventionsprevention3completed
NCT04593654
Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 PatientsNot AvailableNot Availablecompleted
NCT06443905
Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00519805
Dalteparin in Preventing Blood Clots in Patients With Lung Cancersupportive_care3unknown_status
NCT00168805
RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgeryprevention3completed
NCT00024297
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheterssupportive_careNot Availablecompleted
NCT00423683
Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolismtreatment3terminated
NCT05563883
Atrial Fibrillation and Cancer: a Nationwide French Cohort StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00038961
A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).prevention3completed
NCT00064428
OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarctiontreatment3completed
NCT05178628
The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancerprevention3recruiting
NCT04628078
LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closureNo drug interventionsNot AvailableNot Availablerecruiting
NCT03897478
Biomarkers of Acute Stroke in ClinicNo drug interventionsNot AvailableNot Availablerecruiting
NCT00781378
Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in Chinatreatment4completed
NCT00381888
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancertreatment2completed
NCT00662688
Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic CancerNo drug interventionssupportive_care3terminated
NCT01420809
Special Drug Use Investigation for ARIXTRA® (Fondaparinux) InjectionNo drug interventionsNot AvailableNot Availablecompleted
NCT04305756
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean DeliverypreventionNot Availablecompleted
NCT00031837
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancertreatment3terminated
NCT00071032
Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular DiseaseNo drug interventionstreatment3completed
NCT00462852
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancertreatment2completed
NCT00444652
Thromboprophylaxis and Bariatric Surgeryprevention4unknown_status
NCT02779400
Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) MeasurementNo drug interventionsdiagnosticNot Availablecompleted
NCT04813575
COVID-19 Pathophysiology of Long Term ImplicationsNo drug interventionsdiagnosticNot Availableunknown_status
NCT00004875
Heparin or Enoxaparin in Patients With CancerNot AvailableNot Availablecompleted
NCT00964275
Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a VeinNo drug interventionsdiagnosticNot Availablecompleted
NCT03877770
DVT After Cardiac ProcedureNo drug interventionsNot AvailableNot Availablecompleted
NCT00830570
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice SettingsNo drug interventionsNot AvailableNot Availablecompleted
NCT03854149
Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02564718
Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonatesother1 / 2completed
NCT05256524
Is Anti-Factor Xa Associated With Outcome in Patients With Critical COVID-19 on Low-Molecular-Weight Heparin?No drug interventionsNot AvailableNot Availablecompleted
NCT00203658
Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarintreatment4completed
NCT01094886
Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacementprevention3completed
NCT02064439
Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)prevention3completed
NCT01004939
Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous ThromboembolismNot AvailableNot Availablecompleted
NCT01565239
Fiix-prothrombin Time for Monitoring WarfarinNo drug interventionstreatment2completed
NCT00291330
Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolismtreatment3completed
NCT02094157
Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantationtreatment3terminated
NCT00041457
Epidemiology of Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT02913326
A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)treatment3completed
NCT00839826
ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trialprevention2completed
NCT02776566
Patient-Centered Anticoagulation Self-Monitoring in Minority PatientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT05575466
Thromboembolism in Anorexia NervosaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05313620
Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Eventstreatment4recruiting
NCT04719182
Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19No drug interventionsNot AvailableNot Availablecompleted
NCT01006876
Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablationprevention3completed
NCT00794560
Self-management of Low Molecular Weight Heparin TherapyNo drug interventionssupportive_care4completed
NCT01707394
Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorderother1completed
NCT04301362
Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00203580
Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)treatment4completed
NCT06062329
SYMPHONY-PE Study for Treatment of Pulmonary EmbolismNo drug interventionstreatmentNot Availablerecruiting
NCT00020189
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancertreatment2completed
NCT00362492
Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee ReplacementNo drug interventionsprevention4completed
NCT03855592
Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"No drug interventionsNot AvailableNot Availablerecruiting
NCT06442267
Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Supportprevention4recruiting
NCT01319201
Subclinical Atherosclerosis Using Dual-source CT Coronary Angiography in Chinese Adults With Different Glycaemic StatusNo drug interventionsNot AvailableNot Availableunknown_status
NCT00847301
Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT02103101
Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse EventsNo drug interventionsdiagnosticNot Availablecompleted
NCT01452568
Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirintreatment4completed
NCT04616846
Thromboembolic Risk Screening in Patients With Cancer and COVID-19No drug interventionsscreeningNot Availablecompleted
NCT04499612
Influence of Cardiac Implantable Electronic Devices on the Hemostatic SystemNo drug interventionsNot AvailableNot Availablecompleted
NCT05548010
Venous Thromboembolism (VTE) KnowledgeNo drug interventionsNot AvailableNot Availablerecruiting
NCT02447081
Amplatzer™Amulet™ Post-Market Study (Amulet™PMS)No drug interventionsNot AvailableNot Availablecompleted
NCT04686981
Endovascular thromBectomy of Acute Mesentery Vessels Occlusion Hybrid With Emergent Laparoscopic SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT01505881
Follow on Study From RE-ALIGNprevention2terminated
NCT01068795
Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy OutcomepreventionNot Availablecompleted
NCT01541995
Evaluation of Contrast Medium Enhanced Post-mortem CT in Virtual AutopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT00982514
Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008No drug interventionsNot AvailableNot Availableunknown_status
NCT01372514
Institutional Registry of Thromboembolic DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT00000614
Prevention of Recurrent Venous Thromboembolism (PREVENT)prevention3completed
NCT03659708
Pregnancy and Risk of Venous ThromboembolismNo drug interventionspreventionNot Availablerecruiting
NCT02964208
AMPLATZER™ LAA Occluder Post Approval Study (PAS)No drug interventionsNot AvailableNot Availablecompleted
NCT00539045
Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial InfarctionNo drug interventionsNot AvailableNot Availablecompleted
NCT05841524
Vector Velocity Imaging in AAA PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01410539
Mechanism Of Stent Thrombosis (MOST) StudyNo drug interventionstreatment4completed
NCT05307965
RETRIEVE-AMI StudyNo drug interventionstreatmentNot Availablerecruiting
NCT02945280
Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosistreatment4terminated
NCT04229433
The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy SubjectsNo drug interventionstreatment1completed
NCT01281033
CompariSon of Manual Aspiration With Rheolytic Thrombectomy in Patients Undergoing Primary PCI. The SMART-PCI TrialNo drug interventionstreatment4completed
NCT05382078
Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01942070
A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial InfarctionNo drug interventionstreatmentNot Availableunknown_status
NCT05386342
A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy CathetersNo drug interventionstreatmentNot Availablerecruiting
NCT01124942
MGuard Stent in ST-elevation Myocardial InfarctionNo drug interventionstreatmentNot Availablecompleted
NCT05870449
The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC ComplicationsNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01147796
Accuracy of the 64 Slices Computed Tomography for the Diagnosis of Left Atrial Appendage ThrombusNo drug interventionsdiagnosticNot Availableterminated
NCT05007535
Tissue Characterization and Primary Percutaneous Coronary Intervention Guidance Using Intravascular UltrasoundNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01328691
Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor ThrombusNo drug interventionsNot AvailableNot Availablecompleted
NCT00914472
Comparison of Two Heparin Formulations in Patients With Chronic Renal Failure.prevention3unknown_status